JP2019528760A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019528760A5 JP2019528760A5 JP2019517047A JP2019517047A JP2019528760A5 JP 2019528760 A5 JP2019528760 A5 JP 2019528760A5 JP 2019517047 A JP2019517047 A JP 2019517047A JP 2019517047 A JP2019517047 A JP 2019517047A JP 2019528760 A5 JP2019528760 A5 JP 2019528760A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cells
- modified
- population
- unnatural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020168576A JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2026017764A JP2026108616A (ja) | 2016-09-30 | 2026-02-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662402707P | 2016-09-30 | 2016-09-30 | |
| US62/402,707 | 2016-09-30 | ||
| US201762502508P | 2017-05-05 | 2017-05-05 | |
| US62/502,508 | 2017-05-05 | ||
| US201762553058P | 2017-08-31 | 2017-08-31 | |
| US62/553,058 | 2017-08-31 | ||
| US201762556309P | 2017-09-08 | 2017-09-08 | |
| US62/556,309 | 2017-09-08 | ||
| PCT/US2017/054799 WO2018064681A1 (en) | 2016-09-30 | 2017-10-02 | Modified stem cell memory t cells, methods of making and methods of using same |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168576A Division JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Division JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019528760A JP2019528760A (ja) | 2019-10-17 |
| JP2019528760A5 true JP2019528760A5 (cg-RX-API-DMAC10.html) | 2020-11-12 |
Family
ID=60245180
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019517047A Pending JP2019528760A (ja) | 2016-09-30 | 2017-10-02 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2020168576A Active JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Pending JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A Active JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2026017764A Pending JP2026108616A (ja) | 2016-09-30 | 2026-02-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020168576A Active JP7610948B2 (ja) | 2016-09-30 | 2020-10-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2021156988A Pending JP2021191312A (ja) | 2016-09-30 | 2021-09-27 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2024076779A Active JP7817312B2 (ja) | 2016-09-30 | 2024-05-09 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
| JP2026017764A Pending JP2026108616A (ja) | 2016-09-30 | 2026-02-05 | 改変された幹細胞メモリーｔ細胞、その作製方法およびその使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP3519561A1 (cg-RX-API-DMAC10.html) |
| JP (5) | JP2019528760A (cg-RX-API-DMAC10.html) |
| KR (4) | KR20250011252A (cg-RX-API-DMAC10.html) |
| CN (1) | CN110199015A (cg-RX-API-DMAC10.html) |
| AU (4) | AU2017337147A1 (cg-RX-API-DMAC10.html) |
| CA (3) | CA3105873A1 (cg-RX-API-DMAC10.html) |
| IL (3) | IL287286B (cg-RX-API-DMAC10.html) |
| SG (2) | SG11201901959YA (cg-RX-API-DMAC10.html) |
| WO (1) | WO2018064681A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110199015A (zh) * | 2016-09-30 | 2019-09-03 | 波赛达治疗公司 | 修饰干细胞记忆t细胞、其制造方法与使用方法 |
| US20190119636A1 (en) | 2017-10-23 | 2019-04-25 | Poseida Therapeutics, Inc. | Modified stem cell memory t cells, methods of making and methods of using same |
| CA3047313A1 (en) | 2016-12-16 | 2018-06-21 | B-Mogen Biotechnologies, Inc. | Enhanced hat family transposon-mediated gene transfer and associated compositions, systems, and methods |
| US11278570B2 (en) | 2016-12-16 | 2022-03-22 | B-Mogen Biotechnologies, Inc. | Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods |
| EP3351263A1 (en) | 2017-01-20 | 2018-07-25 | Universitätsklinikum Hamburg-Eppendorf | Pharmaceutical preparation for treating or preventing tissue adhesion |
| UA129696C2 (uk) | 2017-08-18 | 2025-07-09 | Ньютроліс Інк. | СКОНСТРУЙОВАНІ ФЕРМЕНТИ ДНКази ТА ЇХНЄ ЗАСТОСУВАННЯ В ТЕРАПІЇ |
| US20210015866A1 (en) * | 2018-03-23 | 2021-01-21 | La Jolla Institute For Allergy And Immunology | Tissue resident memory cell profiles, and uses thereof |
| WO2019246486A2 (en) | 2018-06-21 | 2019-12-26 | B-Mogen Biotechnologies, Inc. | ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS |
| US11058724B2 (en) * | 2018-10-08 | 2021-07-13 | Neutrolis, Inc. | Methods of using DNASE1-like 3 in therapy |
| CN112996911A (zh) | 2018-10-08 | 2021-06-18 | 纽特雷斯股份有限公司 | 用于制造和疗法的脱氧核糖核酸酶的工程改造 |
| US11352613B2 (en) | 2019-02-04 | 2022-06-07 | Neutrolis, Inc. | Engineered human extracellular DNASE enzymes |
| SG11202108357PA (en) | 2019-02-15 | 2021-08-30 | Crispr Therapeutics Ag | Gene editing for hemophilia a with improved factor viii expression |
| EP3959305A1 (en) * | 2019-04-26 | 2022-03-02 | Allogene Therapeutics, Inc. | Methods of manufacturing allogeneic car t cells |
| BR112021015776A2 (pt) * | 2019-06-05 | 2021-11-09 | Bayer Healthcare Llc | Edição de gene para hemofilia a com expressão de fator viii melhorada |
| CN110358734B (zh) | 2019-06-13 | 2020-08-25 | 首都医科大学宣武医院 | 以Tcm为主要效应成分的CAR-T制备方法及其应用 |
| MX2022007107A (es) * | 2019-12-11 | 2022-11-14 | Myeloid Therapeutics Inc | Composiciones celulares terapeuticas y metodos de preparacion y usos de las mismas. |
| EP4110356A4 (en) * | 2020-02-28 | 2024-03-27 | Wisconsin Alumni Research Foundation | NON-VIRAL GENERATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS OBTAINED BY GENE EDITING |
| AU2021236391A1 (en) | 2020-03-13 | 2022-09-29 | Capricor, Inc. | Exosomal nucleic acid vaccine modularly configured to harness multiple antigen presentation mechanisms |
| WO2021222479A1 (en) | 2020-04-28 | 2021-11-04 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| EP4298205A1 (en) * | 2021-02-23 | 2024-01-03 | Poseida Therapeutics, Inc. | Genetically modified induced pluripotent stem cells and methods of use thereof |
| CN114990061B (zh) * | 2022-06-30 | 2023-08-29 | 河南省人民医院 | 一种诱导扩增中央记忆性t细胞的培养方法 |
| CN116444666A (zh) * | 2023-05-22 | 2023-07-18 | 上海交通大学医学院附属仁济医院 | Cdh17特异性诊疗一体化分子影像探针的制备方法及应用 |
| WO2025221789A1 (en) | 2024-04-16 | 2025-10-23 | Poseida Therapeutics, Inc. | Compositions and methods for use in car/tcr cell therapies |
| CN118272305B (zh) * | 2024-04-29 | 2025-04-08 | 深圳泽医细胞治疗集团有限公司 | 一种免疫细胞的培养基及其应用 |
| CN118813532A (zh) * | 2024-07-30 | 2024-10-22 | 中国医学科学院基础医学研究所 | 体外制备与扩增tscm细胞的方法 |
| CN118813707A (zh) * | 2024-07-30 | 2024-10-22 | 中国医学科学院基础医学研究所 | 体外制备与扩增干性car-t细胞的方法 |
| WO2026080393A1 (en) | 2024-10-07 | 2026-04-16 | Poseida Therapeutics, Inc. | Compositions and methods for use in car cell therapies |
| WO2026107088A1 (en) | 2024-11-13 | 2026-05-21 | Poseida Therapeutics, Inc. | Dual car constructs and methods of use |
| WO2026107078A1 (en) | 2024-11-13 | 2026-05-21 | Poseida Therapeutics, Inc. | Chimeric antigen receptor compositions and methods of use |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US5266491A (en) | 1989-03-14 | 1993-11-30 | Mochida Pharmaceutical Co., Ltd. | DNA fragment and expression plasmid containing the DNA fragment |
| US5580734A (en) | 1990-07-13 | 1996-12-03 | Transkaryotic Therapies, Inc. | Method of producing a physical map contigous DNA sequences |
| US5641670A (en) | 1991-11-05 | 1997-06-24 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| US5968502A (en) | 1991-11-05 | 1999-10-19 | Transkaryotic Therapies, Inc. | Protein production and protein delivery |
| AU7082694A (en) * | 1994-05-10 | 1995-11-29 | Kitasato Institute, The | Hematopoietic stem cell proliferation accelerator |
| US6218185B1 (en) | 1996-04-19 | 2001-04-17 | The United States Of America As Represented By The Secretary Of Agriculture | Piggybac transposon-based genetic transformation system for insects |
| US6835394B1 (en) | 1999-12-14 | 2004-12-28 | The Trustees Of The University Of Pennsylvania | Polymersomes and related encapsulating membranes |
| US7105343B1 (en) | 2000-10-31 | 2006-09-12 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector Piggybac |
| US6962810B2 (en) | 2000-10-31 | 2005-11-08 | University Of Notre Dame Du Lac | Methods and compositions for transposition using minimal segments of the eukaryotic transformation vector piggyBac |
| IL152904A0 (en) * | 2002-01-24 | 2003-06-24 | Gamida Cell Ltd | Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations |
| CA2495824A1 (en) * | 2002-08-19 | 2004-02-26 | Gamida-Cell Ltd. | Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| EP4733396A2 (en) | 2009-02-26 | 2026-04-29 | Poseida Therapeutics, Inc. | Hyperactive piggybac transposases |
| CN107070622B (zh) * | 2009-06-02 | 2021-02-09 | 太阳专利信托公司 | 终端装置、通信装置、通信方法和集成电路 |
| US8808748B2 (en) | 2010-04-20 | 2014-08-19 | Vindico NanoBio Technology Inc. | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| WO2012094679A2 (en) | 2011-01-07 | 2012-07-12 | Vindico NanoBio Technology Inc. | Compositions and methods for delivery of high-affinity oxygen binding agents to tumors |
| PT3434775T (pt) | 2011-06-07 | 2020-04-08 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Proteína que tem atividade de nuclease, proteínas de fusão e utilizações das mesmas |
| EP2814846B1 (en) * | 2012-02-13 | 2020-01-08 | Seattle Children's Hospital d/b/a Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| CN105408483A (zh) | 2013-03-15 | 2016-03-16 | 通用医疗公司 | 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向 |
| AU2014235968B2 (en) * | 2013-03-21 | 2018-05-24 | Ospedale San Raffaele Srl | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| EP2997134B1 (en) * | 2013-05-14 | 2020-06-24 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CN122399016A (zh) * | 2014-03-15 | 2026-07-17 | 诺华股份有限公司 | 使用嵌合抗原受体治疗癌症 |
| HUE052552T2 (hu) * | 2014-04-09 | 2021-05-28 | Dna Twopointo Inc | Javított nukleinsav-konstrukciók eukarióta génexpresszióhoz |
| US10738278B2 (en) * | 2014-07-15 | 2020-08-11 | Juno Therapeutics, Inc. | Engineered cells for adoptive cell therapy |
| AU2015301014B2 (en) | 2014-08-08 | 2021-05-06 | Poseida Therapeutics, Inc. | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| BR112017004270B1 (pt) * | 2014-09-04 | 2023-03-07 | Stemcell Technologies Inc | Método de ativação de células t ou células nk |
| EP3018200A1 (en) * | 2014-11-07 | 2016-05-11 | Fondazione Matilde Tettamanti e Menotti de Machi Onlus | Improved method for the generation of genetically modified cells |
| AU2015358413A1 (en) | 2014-12-05 | 2017-06-29 | Poseida Therapeutics, Inc. | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| RU2751362C2 (ru) * | 2014-12-29 | 2021-07-13 | Новартис Аг | Способы получения экспрессирующих химерный антигенный рецептор клеток |
| JP2018521689A (ja) * | 2015-06-17 | 2018-08-09 | ポセイダ セラピューティクス， インコーポレイテッド | タンパク質をゲノム内の特定の遺伝子座に導くための組成物および方法 |
| US10456452B2 (en) | 2015-07-02 | 2019-10-29 | Poseida Therapeutics, Inc. | Compositions and methods for improved encapsulation of functional proteins in polymeric vesicles |
| US20170000743A1 (en) | 2015-07-02 | 2017-01-05 | Vindico NanoBio Technology Inc. | Compositions and Methods for Delivery of Gene Editing Tools Using Polymeric Vesicles |
| CN110199015A (zh) * | 2016-09-30 | 2019-09-03 | 波赛达治疗公司 | 修饰干细胞记忆t细胞、其制造方法与使用方法 |
-
2017
- 2017-10-02 CN CN201780073874.1A patent/CN110199015A/zh active Pending
- 2017-10-02 WO PCT/US2017/054799 patent/WO2018064681A1/en not_active Ceased
- 2017-10-02 EP EP17794119.2A patent/EP3519561A1/en active Pending
- 2017-10-02 AU AU2017337147A patent/AU2017337147A1/en not_active Abandoned
- 2017-10-02 KR KR1020257001336A patent/KR20250011252A/ko active Pending
- 2017-10-02 CA CA3105873A patent/CA3105873A1/en not_active Abandoned
- 2017-10-02 SG SG11201901959YA patent/SG11201901959YA/en unknown
- 2017-10-02 JP JP2019517047A patent/JP2019528760A/ja active Pending
- 2017-10-02 KR KR1020197011671A patent/KR20190063468A/ko not_active Ceased
- 2017-10-02 KR KR1020207026327A patent/KR102588469B1/ko active Active
- 2017-10-02 CA CA3036926A patent/CA3036926C/en active Active
- 2017-10-02 SG SG10202007963SA patent/SG10202007963SA/en unknown
- 2017-10-02 KR KR1020237007633A patent/KR102757155B1/ko active Active
- 2017-10-02 CA CA3154236A patent/CA3154236C/en active Active
- 2017-10-02 IL IL287286A patent/IL287286B/en unknown
-
2019
- 2019-03-04 IL IL265157A patent/IL265157B/en active IP Right Grant
-
2020
- 2020-08-25 IL IL276907A patent/IL276907B/en unknown
- 2020-09-01 AU AU2020227020A patent/AU2020227020B2/en active Active
- 2020-10-05 JP JP2020168576A patent/JP7610948B2/ja active Active
-
2021
- 2021-09-27 JP JP2021156988A patent/JP2021191312A/ja active Pending
-
2022
- 2022-09-23 AU AU2022235633A patent/AU2022235633B2/en active Active
-
2024
- 2024-05-09 JP JP2024076779A patent/JP7817312B2/ja active Active
-
2025
- 2025-04-29 AU AU2025203005A patent/AU2025203005A1/en active Pending
-
2026
- 2026-02-05 JP JP2026017764A patent/JP2026108616A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4427809A3 (en) | Altering gene expression in car-t cells and uses thereof | |
| JP2013176400A5 (cg-RX-API-DMAC10.html) | ||
| IL287286B (en) | Differentiated stem cell memory t cells, methods for their preparation and methods for using them | |
| MX395574B (es) | Metodo y composiciones para inmunoterapia celular. | |
| JP2013501505A5 (cg-RX-API-DMAC10.html) | ||
| MX2018014941A (es) | Anticuerpo para unirse al receptor de interleucina 4. | |
| EA201891212A1 (ru) | Адресная дезорганизация клеточного рецептора гкгс | |
| JP2017512484A5 (cg-RX-API-DMAC10.html) | ||
| EA201890772A1 (ru) | Способ высокоуровневого и стабильного переноса генов в лимфоцитах | |
| HK1216894A1 (zh) | 多價結合蛋白組合物 | |
| NZ705675A (en) | Engineered transgene integration platform (etip) for gene targeting and trait stacking | |
| JP2016500260A5 (cg-RX-API-DMAC10.html) | ||
| EP4218409A3 (en) | Mice expressing a limited immunoglobulin light chain repertoire | |
| CY1123348T1 (el) | Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης | |
| JP2019534684A5 (cg-RX-API-DMAC10.html) | ||
| EP3587560A4 (en) | Endodermal cell mass, and method for producing any one of three primary germ layer cell mass from pluripotent cells | |
| Sikorskaya | Noosferic aspects of networked collaborations among vocational educational institutions in Russia | |
| PL415351A1 (pl) | Sposób namnażania in vitro komórek T regulatorowych (Treg) | |
| JP2013503602A5 (cg-RX-API-DMAC10.html) | ||
| JP2014533495A5 (cg-RX-API-DMAC10.html) | ||
| Kornienko | PRINCIPLES OF FORMING OF SYSTEM OF ECONOMIC ANALYSIS ARE IN MANAGEMENT ENTERPRISE | |
| Phuc et al. | Visualization of the Epiblast and Visceral Endodermal Cells Using Fgf5-P2A-Venus BAC Transgenic Mice and Epiblast Stem Cells | |
| Metelitsa | AN ANALYSIS OF DIFFICULTIES READING ACADEMIC ARTCILES OF STUDENTS OF TECHNICAL SPECIALISATIONS AND ATTEMPTS TO SOLVE THEM | |
| Konishchev et al. | EARTH'S CRYOSPHERE | |
| Pavlova et al. | PREPARATORY PROCESS FOR PUPILS TO THE OLYMPIADS IN INFORMATICS |